GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $72.6 million in its first quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.32.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.18 per share.
The biopharmaceutical company posted revenue of $5.3 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $16.4 million.
Theravance Bio shares have decreased 4.5% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $24.45, a climb of roughly 4% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TBPH at https://www.zacks.com/ap/TBPH